Hematopoiesis reconstitution and anti-tumor effectiveness of Pai-Neng-Da capsule in acute leukemia patients with haploidentical hematopoietic stem cell transplantation

Table 2 The mean peripheral blood cell counts after haploidentical hematopoietic stem cell transplantation according to treatment group (mean ± SD)

Group	Case	Days after transplantation	Neutrophil count (109/L)	Hemoglobin concentration (g/L)	Platelet count (109/L)
Non-PND	31	6	0.12 ± 0.05	93.35 ± 15.23	21.55 ± 13.27
		12	1.61 ± 1.15	73.97 ± 7.67	27.65 ± 11.96
		18	2.78 ± 2.29	84.90 ± 12.17	45.03 ± 31.40
		24	3.01 ± 1.15	86.65 ± 11.70	68.39 ± 49.61
		30	3.21 ± 1.60	93.81 ± 16.94	76.65 ± 52.66
PND	29	6	0.10 ± 0.04	95.55 ± 14.13	19.55 ± 8.47
		12	1.87 ± 1.18	78.41 ± 10.01	28.07 ± 12.49
		18	2.86 ± 1.37	92.83 ± 14.58a	67.55 ± 35.63a
		24	3.28 ± 1.47	99.55 ± 17.83a	81.90 ± 38.37a
		30	3.36 ± 1.15	103.66 ± 19.22 a	82.31 ± 37.70

^aP < 0.05 vs non-PND group.

PND: Pai-Neng-Da.